Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
PREVAC Study Team; Kieh M, Richert L, Beavogui AH, Grund B, Leigh B, D'Ortenzio E, Doumbia S, Lhomme E, Sow S, Vatrinet R, Roy C, Kennedy SB, Faye S, Lees S, Millimouno NP, Camara AM, Samai M, Deen GF, Doumbia M, Espérou H, Pierson J, Watson-Jones D, Diallo A, Wentworth D, McLean C, Simon J, Wiedemann A, Dighero-Kemp B, Hensley L, Lane HC, Levy Y, Piot P, Greenwood B, Chêne G, Neaton J, Yazdanpanah Y. PREVAC Study Team, et al. N Engl J Med. 2022 Dec 29;387(26):2411-2424. doi: 10.1056/NEJMoa2200072. Epub 2022 Dec 14. N Engl J Med. 2022. PMID: 36516078 Clinical Trial.
USPHS Corps Care : Force Health Protection for Public Health Officers During the Ebola and COVID-19 Responses.
Myles IA, Johnson DR, Pham H, Adams A, Anderson J, Banks-Shields M, Battle AG, Demby ML, Hastings D, Lewis RM, Pauli IB, Vedder JAM, Weeks C, Willbright ML, Guyton CB, Orsega S, Litton-Belcher KS. Myles IA, et al. Among authors: orsega s. Public Health Rep. 2021 Mar-Apr;136(2):148-153. doi: 10.1177/0033354920984775. Epub 2021 Feb 4. Public Health Rep. 2021. PMID: 33541219 Free PMC article.
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Badio M, Lhomme E, Kieh M, Beavogui AH, Kennedy SB, Doumbia S, Leigh B, Sow SO, Diallo A, Fusco D, Kirchoff M, Termote M, Vatrinet R, Wentworth D, Esperou H, Lane HC, Pierson J, Watson-Jones D, Roy C, D'Ortenzio E, Greenwood B, Chêne G, Richert L, Neaton JD, Yazdanpanah Y; PREVAC study team. Badio M, et al. Trials. 2021 Jan 23;22(1):86. doi: 10.1186/s13063-021-05035-9. Trials. 2021. PMID: 33485369 Free PMC article.
Evolution of Mycobacterium tuberculosis complex lineages and their role in an emerging threat of multidrug resistant tuberculosis in Bamako, Mali.
Senghore M, Diarra B, Gehre F, Otu J, Worwui A, Muhammad AK, Kwambana-Adams B, Kay GL, Sanogo M, Baya B, Orsega S, Doumbia S, Diallo S, de Jong BC, Pallen MJ, Antonio M. Senghore M, et al. Among authors: orsega s. Sci Rep. 2020 Jan 15;10(1):327. doi: 10.1038/s41598-019-56001-0. Sci Rep. 2020. PMID: 31941887 Free PMC article.
Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali.
Baya B, Achenbach CJ, Kone B, Toloba Y, Dabitao DK, Diarra B, Goita D, Diabaté S, Maiga M, Soumare D, Ouattara K, Kanoute T, Berthe G, Kamia YM, Sarro YDS, Sanogo M, Togo ACG, Dembele BPP, Coulibaly N, Kone A, Akanbi M, Belson M, Dao S, Orsega S, Siddiqui S, Doumbia S, Murphy RL, Diallo S. Baya B, et al. Among authors: orsega s. Int J Infect Dis. 2019 Apr;81:149-155. doi: 10.1016/j.ijid.2019.02.004. Epub 2019 Feb 14. Int J Infect Dis. 2019. PMID: 30772470 Free PMC article.
Diagnostic Performances of Three Rapid Diagnostic Tests for Detecting HIV Infections in Mali.
Kone B, Sarro YS, Baya B, Dabitao D, Coulibaly N, Wague M, Diarra B, Guindo O, Sanogo M, Togo AC, Kone A, Goita D, Diabate S, Kodio O, Belson M, Dao S, Orsega S, Murphy RL, Diallo S, Doumbia S, Siddiqui S, Maiga M. Kone B, et al. Among authors: orsega s. Infect Dis Diagn Treat. 2019;3(1):134. Epub 2019 Dec 18. Infect Dis Diagn Treat. 2019. PMID: 34355138 Free PMC article.
Mycobacterium africanum (Lineage 6) shows slower sputum smear conversion on tuberculosis treatment than Mycobacterium tuberculosis (Lineage 4) in Bamako, Mali.
Diarra B, Kone M, Togo ACG, Sarro YDS, Cisse AB, Somboro A, Degoga B, Tolofoudie M, Kone B, Sanogo M, Baya B, Kodio O, Maiga M, Belson M, Orsega S, Krit M, Dao S, Maiga II, Murphy RL, Rigouts L, Doumbia S, Diallo S, de Jong BC. Diarra B, et al. Among authors: orsega s. PLoS One. 2018 Dec 12;13(12):e0208603. doi: 10.1371/journal.pone.0208603. eCollection 2018. PLoS One. 2018. PMID: 30540823 Free PMC article.
33 results